KLK3 and neoplasm: We recommend to offer adjuvant RT to all patients with R1 resection and pT3 disease and to also consider preoperative PSA values of more than 10 ng/mL and a preoperative PSA velocity of >2 ng/mL per year as additional risk factors for tumor recurrence.